首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1741528

虚拟肿瘤学市场：按成分、癌症类型、应用、最终用户和地区划分

Virtual Oncology Market, By Component, By Cancer Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

虚拟肿瘤学市场规模预计在 2025 年为 47.3 亿美元，预计到 2032 年将达到 149.8 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 17.9%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	47.3亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	17.90%	2032年价值预测	149.8亿美元

虚拟肿瘤学是医疗保健领域的一个新兴领域，它利用科技提供远距癌症护理和支援服务。它涵盖各种数位解决方案，包括远端医疗、虚拟会诊、远端监控和个人化治疗方案。虚拟肿瘤学的目标是改善患者预后，增加医疗服务可近性，并提升患者的整体体验。

由于技术进步和全球癌症发生率的不断上升，虚拟肿瘤学近年来获得了广泛支持。这种方法具有许多优势，包括减少患者出行时间和费用、更便捷地获取专家意见，以及能够远端监控患者的健康状况。它还可以根据患者的个人需求和偏好，提供更个人化的治疗方案。

市场动态：

由于癌症发病率上升、远距医疗服务需求成长、技术进步等因素，虚拟肿瘤学市场预计将在未来几年显着成长。此外，由于医院和诊所专注于减少面对面咨询并最大限度地降低感染风险，COVID-19 疫情进一步加速了虚拟肿瘤学解决方案的采用。

然而，一些挑战可能会抑制市场的成长。资料安全、病患隐私和监管壁垒等担忧是市场相关人员面临的主要障碍。此外，熟悉虚拟技术的熟练医疗专业人员的短缺以及实施此类系统的高成本也可能限制市场扩张。

然而，虚拟肿瘤学市场为现有和新进入者提供了许多机会。人工智慧 (AI) 和机器学习演算法在虚拟肿瘤学中的应用日益广泛，有助于改善诊断、治疗计划和病患监测。此外，科技公司与医疗保健提供者合作开发创新解决方案并增强病人参与，预计将推动市场发展。

本研究的主要特点

本报告对全球虚拟肿瘤学市场进行了详细分析，包括市场规模（十亿美国）和预测期 2025-2032 的年复合成长率（CAGR%），以 2024 年为基准年。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球虚拟肿瘤学市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
研究中主要企业包括 Flatiron Health、McKesson Corporation、Cerner Corporation、Koninklijke Philips NV、Siemens Healthcare Private Limited、Crisp、Varian Medical Systems, Inc.、Elekta AB、Accuray Incorporated、C-TAC Health、Oscar Health、NXGN Management, Inc. Medical。
本报告的见解将使负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
全球虚拟肿瘤学市场报告针对行业中的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以从全球虚拟肿瘤学市场分析中使用的各种策略矩阵中受益，这可以帮助他们进行决策流程。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.73 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	17.90%	2032 Value Projection:	USD 14.98 Bn

Virtual oncology is an emerging field in healthcare that utilizes technology to provide remote cancer care and support services. It encompasses various digital solutions such as telemedicine, virtual consultations, remote monitoring, and personalized treatment plans. The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience.

With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained significant traction in recent years. This approach offers several benefits, including reduced travel time and costs for patients, improved access to expert opinions, and the ability to monitor patients' health remotely. It also allows for more personalized treatment options based on individual patient needs and preferences.

Market Dynamics:

The virtual oncology market is expected to witness substantial growth in the coming years, primarily driven by factors such as the increasing prevalence of cancer, the growing need for remote healthcare services, and advancements in technology. Additionally, the COVID-19 pandemic has further accelerated the adoption of virtual oncology solutions as hospitals and clinics focus on reducing in-person visits and minimizing the risk of infections.

However, there are certain challenges that may restrain market growth. Concerns regarding data security and patient privacy, along with regulatory barriers, pose significant hurdles for market players. Moreover, the lack of skilled healthcare professionals proficient in virtual technologies and the high costs associated with implementing such systems may limit the market's expansion.

Nevertheless, the virtual oncology market presents several opportunities for both existing and new market players. The increasing adoption of artificial intelligence (AI) and machine learning algorithms in virtual oncology can help improve diagnosis, treatment planning, and patient monitoring. Additionally, collaborations between technology companies and healthcare providers to develop innovative solutions and enhance patient engagement are expected to drive market growth.

Key Features of the Study:

This report provides in-depth analysis of the global virtual oncology market, including market size (in US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global virtual oncology market based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
Key companies covered in this study include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical
Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
The global virtual oncology market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders will benefit from the various strategy matrices used in analyzing the global virtual oncology market, which will aid in decision-making processes.

Virtual Oncology Market Segmentation:

Virtual Oncology Market, By Component
- Software
- Service
- Hardware
Virtual Oncology Market, By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Others (Pancreatic, Ovarian etc.)
Virtual Oncology Market, By Application
- Precision Medicine
- Patient Care Management
- Research & Development
- Clinical Trials
- Diagnosis & Treatment Decision Making
- Data Management
- Others (Billing Management, Regulatory Compliance etc.)
Virtual Oncology Market, By End User
- Hospitals & Diagnostic Imaging Centers
- Academic Institutions & Research Centers
- Pharma & Biotech Companies
- Contract Research Organizations (CROs)
- Others (Reference Laboratories, Pharmacies etc.)
Virtual Oncology Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Flatiron Health
- McKesson Corporation
- Cerner Corporation
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- Crisp
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- C-TAC Health
- Oscar Health
- NXGN Management, LLC
- Epic Systems Corporation
- Optum, Inc
- CureMatch, Inc.
- Oncora Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Virtual Oncology, By Component
- Market Virtual Oncology, By Cancer Type
- Market Virtual Oncology, By Application
- Market Virtual Oncology, By End User
- Market Virtual Oncology, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of cancer globally
- Restraints
Data privacy and security concerns
- Opportunities
Emerging markets exhibit significant growth potential
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Virtual Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Virtual Oncology Market , By Component, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Virtual Oncology Market, By Cancer Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Pancreatic, Ovarian etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Virtual Oncology Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Patient Care Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Clinical Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnosis & Treatment Decision Making
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Billing Management, Regulatory Compliance etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Virtual Oncology Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals & Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Academic Institutions & Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Reference Laboratories, Pharmacies etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Virtual Oncology Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - South Africa
  - Central Africa

10. Competitive Landscape

Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cerner Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Crisp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Varian Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Elekta AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
C-TAC Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oscar Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NXGN Management, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Optum, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CureMatch, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oncora Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

虚拟肿瘤学市场：按成分、癌症类型、应用、最终用户和地区划分